Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Equity Ratio (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Equity Ratio data on record, last reported at 0.36 in Q3 2025.

  • For Q3 2025, Equity Ratio rose 458.5% year-over-year to 0.36; the TTM value through Sep 2025 reached 0.36, up 458.5%, while the annual FY2024 figure was 0.01, 220.33% down from the prior year.
  • Equity Ratio reached 0.36 in Q3 2025 per FBIO's latest filing, up from 0.23 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.62 in Q1 2021 and bottomed at 0.1 in Q3 2024.
  • Average Equity Ratio over 5 years is 0.22, with a median of 0.18 recorded in 2025.
  • Peak YoY movement for Equity Ratio: plummeted 220.33% in 2024, then surged 862.93% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.57 in 2021, then plummeted by 70.16% to 0.17 in 2022, then tumbled by 94.43% to 0.01 in 2023, then crashed by 220.33% to 0.01 in 2024, then soared by 3252.29% to 0.36 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.36 in Q3 2025, 0.23 in Q2 2025, and 0.18 in Q1 2025.